Insomnia Symptoms in Patients With Substance Use Disorders During Detoxification and Associated Clinical Features
Background: Insomnia is highly prevalent in patients with substance use disorders (SUD), and it has been related to a worse course of addiction. Insomnia during detoxification in a hospital has not been adequately studied. This study aims to compare sociodemographic, clinical, and psychopathological...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-11-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2020.540022/full |
_version_ | 1818555165573120000 |
---|---|
author | Lara Grau-López Lara Grau-López Lara Grau-López Lara Grau-López Laia Grau-López Constanza Daigre Constanza Daigre Constanza Daigre Raúl Felipe Palma-Álvarez Raúl Felipe Palma-Álvarez Raúl Felipe Palma-Álvarez Raúl Felipe Palma-Álvarez Nieves Martínez-Luna Nieves Martínez-Luna Nieves Martínez-Luna Nieves Martínez-Luna Elena Ros-Cucurull Elena Ros-Cucurull Elena Ros-Cucurull Elena Ros-Cucurull Jose Antonio Ramos-Quiroga Jose Antonio Ramos-Quiroga Jose Antonio Ramos-Quiroga Jose Antonio Ramos-Quiroga Carlos Roncero Carlos Roncero |
author_facet | Lara Grau-López Lara Grau-López Lara Grau-López Lara Grau-López Laia Grau-López Constanza Daigre Constanza Daigre Constanza Daigre Raúl Felipe Palma-Álvarez Raúl Felipe Palma-Álvarez Raúl Felipe Palma-Álvarez Raúl Felipe Palma-Álvarez Nieves Martínez-Luna Nieves Martínez-Luna Nieves Martínez-Luna Nieves Martínez-Luna Elena Ros-Cucurull Elena Ros-Cucurull Elena Ros-Cucurull Elena Ros-Cucurull Jose Antonio Ramos-Quiroga Jose Antonio Ramos-Quiroga Jose Antonio Ramos-Quiroga Jose Antonio Ramos-Quiroga Carlos Roncero Carlos Roncero |
author_sort | Lara Grau-López |
collection | DOAJ |
description | Background: Insomnia is highly prevalent in patients with substance use disorders (SUD), and it has been related to a worse course of addiction. Insomnia during detoxification in a hospital has not been adequately studied. This study aims to compare sociodemographic, clinical, and psychopathological characteristics of SUD patients undergoing a detoxification program, by comorbidity and insomnia symptoms.Methodology: We recruited 481 patients who received pharmacological and psychotherapeutic treatment for detoxification. They were evaluated through semi-structured interviews, standardized questionnaires, and a specific sleep log. A bivariate and multivariate analysis of the data was performed.Results: Insomnia was reported by 66.5% patients, with sleep-maintenance insomnia the most frequent issue, followed by early morning awakening and sleep-onset insomnia. Patients with alcohol use disorder and cannabis use disorder had higher prevalence of sleep-onset insomnia. Patients with cocaine and heroin use disorder had higher prevalence of sleep-maintenance insomnia. Independent factors that allowed the identification of insomnia symptoms included being female (OR: 3.43), polysubstance use (OR: 2.85), comorbid anxiety disorder (OR: 2.02), and prior admission for detoxification (OR: 1.22).Conclusions: Insomnia symptoms are very prevalent in patients admitted for detoxification. The diagnosis and therapeutic strategies for the insomnia symptoms should be improved, especially in women and in patients with greater addiction severity and with anxiety disorders. |
first_indexed | 2024-12-12T09:49:38Z |
format | Article |
id | doaj.art-fa3b18c60a5842fab8528b2fe94e0bb2 |
institution | Directory Open Access Journal |
issn | 1664-0640 |
language | English |
last_indexed | 2024-12-12T09:49:38Z |
publishDate | 2020-11-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Psychiatry |
spelling | doaj.art-fa3b18c60a5842fab8528b2fe94e0bb22022-12-22T00:28:18ZengFrontiers Media S.A.Frontiers in Psychiatry1664-06402020-11-011110.3389/fpsyt.2020.540022540022Insomnia Symptoms in Patients With Substance Use Disorders During Detoxification and Associated Clinical FeaturesLara Grau-López0Lara Grau-López1Lara Grau-López2Lara Grau-López3Laia Grau-López4Constanza Daigre5Constanza Daigre6Constanza Daigre7Raúl Felipe Palma-Álvarez8Raúl Felipe Palma-Álvarez9Raúl Felipe Palma-Álvarez10Raúl Felipe Palma-Álvarez11Nieves Martínez-Luna12Nieves Martínez-Luna13Nieves Martínez-Luna14Nieves Martínez-Luna15Elena Ros-Cucurull16Elena Ros-Cucurull17Elena Ros-Cucurull18Elena Ros-Cucurull19Jose Antonio Ramos-Quiroga20Jose Antonio Ramos-Quiroga21Jose Antonio Ramos-Quiroga22Jose Antonio Ramos-Quiroga23Carlos Roncero24Carlos Roncero25Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, SpainGroup of Psychiatry, Mental Health and Addiction, Vall d'Hebron Research Institute, Barcelona, SpainBiomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, SpainDepartment of Psychiatry and Forensic Medicine, Autonomous University of Barcelona, Barcelona, SpainDepartment of Neurosciences, Hospital Universitari Germans Trias i Pujol, Badalona, SpainGroup of Psychiatry, Mental Health and Addiction, Vall d'Hebron Research Institute, Barcelona, SpainBiomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, SpainDepartment of Psychiatry and Forensic Medicine, Autonomous University of Barcelona, Barcelona, SpainDepartment of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, SpainGroup of Psychiatry, Mental Health and Addiction, Vall d'Hebron Research Institute, Barcelona, SpainBiomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, SpainDepartment of Psychiatry and Forensic Medicine, Autonomous University of Barcelona, Barcelona, SpainDepartment of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, SpainGroup of Psychiatry, Mental Health and Addiction, Vall d'Hebron Research Institute, Barcelona, SpainBiomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, SpainDepartment of Psychiatry and Forensic Medicine, Autonomous University of Barcelona, Barcelona, SpainDepartment of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, SpainGroup of Psychiatry, Mental Health and Addiction, Vall d'Hebron Research Institute, Barcelona, SpainBiomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, SpainDepartment of Psychiatry and Forensic Medicine, Autonomous University of Barcelona, Barcelona, SpainDepartment of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, SpainGroup of Psychiatry, Mental Health and Addiction, Vall d'Hebron Research Institute, Barcelona, SpainBiomedical Network Research Centre on Mental Health (CIBERSAM), Barcelona, SpainDepartment of Psychiatry and Forensic Medicine, Autonomous University of Barcelona, Barcelona, SpainPsychiatric Service, University of Salamanca Health Care Complex, Institute of Biomedicine of Salamanca, University of Salamanca, Salamanca, SpainPsychiatric Unit, School of Medicine University of Salamanca, Salamanca, SpainBackground: Insomnia is highly prevalent in patients with substance use disorders (SUD), and it has been related to a worse course of addiction. Insomnia during detoxification in a hospital has not been adequately studied. This study aims to compare sociodemographic, clinical, and psychopathological characteristics of SUD patients undergoing a detoxification program, by comorbidity and insomnia symptoms.Methodology: We recruited 481 patients who received pharmacological and psychotherapeutic treatment for detoxification. They were evaluated through semi-structured interviews, standardized questionnaires, and a specific sleep log. A bivariate and multivariate analysis of the data was performed.Results: Insomnia was reported by 66.5% patients, with sleep-maintenance insomnia the most frequent issue, followed by early morning awakening and sleep-onset insomnia. Patients with alcohol use disorder and cannabis use disorder had higher prevalence of sleep-onset insomnia. Patients with cocaine and heroin use disorder had higher prevalence of sleep-maintenance insomnia. Independent factors that allowed the identification of insomnia symptoms included being female (OR: 3.43), polysubstance use (OR: 2.85), comorbid anxiety disorder (OR: 2.02), and prior admission for detoxification (OR: 1.22).Conclusions: Insomnia symptoms are very prevalent in patients admitted for detoxification. The diagnosis and therapeutic strategies for the insomnia symptoms should be improved, especially in women and in patients with greater addiction severity and with anxiety disorders.https://www.frontiersin.org/articles/10.3389/fpsyt.2020.540022/fulladdictioninsomniasleep disorderswomendetoxification processanxiety disorders |
spellingShingle | Lara Grau-López Lara Grau-López Lara Grau-López Lara Grau-López Laia Grau-López Constanza Daigre Constanza Daigre Constanza Daigre Raúl Felipe Palma-Álvarez Raúl Felipe Palma-Álvarez Raúl Felipe Palma-Álvarez Raúl Felipe Palma-Álvarez Nieves Martínez-Luna Nieves Martínez-Luna Nieves Martínez-Luna Nieves Martínez-Luna Elena Ros-Cucurull Elena Ros-Cucurull Elena Ros-Cucurull Elena Ros-Cucurull Jose Antonio Ramos-Quiroga Jose Antonio Ramos-Quiroga Jose Antonio Ramos-Quiroga Jose Antonio Ramos-Quiroga Carlos Roncero Carlos Roncero Insomnia Symptoms in Patients With Substance Use Disorders During Detoxification and Associated Clinical Features Frontiers in Psychiatry addiction insomnia sleep disorders women detoxification process anxiety disorders |
title | Insomnia Symptoms in Patients With Substance Use Disorders During Detoxification and Associated Clinical Features |
title_full | Insomnia Symptoms in Patients With Substance Use Disorders During Detoxification and Associated Clinical Features |
title_fullStr | Insomnia Symptoms in Patients With Substance Use Disorders During Detoxification and Associated Clinical Features |
title_full_unstemmed | Insomnia Symptoms in Patients With Substance Use Disorders During Detoxification and Associated Clinical Features |
title_short | Insomnia Symptoms in Patients With Substance Use Disorders During Detoxification and Associated Clinical Features |
title_sort | insomnia symptoms in patients with substance use disorders during detoxification and associated clinical features |
topic | addiction insomnia sleep disorders women detoxification process anxiety disorders |
url | https://www.frontiersin.org/articles/10.3389/fpsyt.2020.540022/full |
work_keys_str_mv | AT laragraulopez insomniasymptomsinpatientswithsubstanceusedisordersduringdetoxificationandassociatedclinicalfeatures AT laragraulopez insomniasymptomsinpatientswithsubstanceusedisordersduringdetoxificationandassociatedclinicalfeatures AT laragraulopez insomniasymptomsinpatientswithsubstanceusedisordersduringdetoxificationandassociatedclinicalfeatures AT laragraulopez insomniasymptomsinpatientswithsubstanceusedisordersduringdetoxificationandassociatedclinicalfeatures AT laiagraulopez insomniasymptomsinpatientswithsubstanceusedisordersduringdetoxificationandassociatedclinicalfeatures AT constanzadaigre insomniasymptomsinpatientswithsubstanceusedisordersduringdetoxificationandassociatedclinicalfeatures AT constanzadaigre insomniasymptomsinpatientswithsubstanceusedisordersduringdetoxificationandassociatedclinicalfeatures AT constanzadaigre insomniasymptomsinpatientswithsubstanceusedisordersduringdetoxificationandassociatedclinicalfeatures AT raulfelipepalmaalvarez insomniasymptomsinpatientswithsubstanceusedisordersduringdetoxificationandassociatedclinicalfeatures AT raulfelipepalmaalvarez insomniasymptomsinpatientswithsubstanceusedisordersduringdetoxificationandassociatedclinicalfeatures AT raulfelipepalmaalvarez insomniasymptomsinpatientswithsubstanceusedisordersduringdetoxificationandassociatedclinicalfeatures AT raulfelipepalmaalvarez insomniasymptomsinpatientswithsubstanceusedisordersduringdetoxificationandassociatedclinicalfeatures AT nievesmartinezluna insomniasymptomsinpatientswithsubstanceusedisordersduringdetoxificationandassociatedclinicalfeatures AT nievesmartinezluna insomniasymptomsinpatientswithsubstanceusedisordersduringdetoxificationandassociatedclinicalfeatures AT nievesmartinezluna insomniasymptomsinpatientswithsubstanceusedisordersduringdetoxificationandassociatedclinicalfeatures AT nievesmartinezluna insomniasymptomsinpatientswithsubstanceusedisordersduringdetoxificationandassociatedclinicalfeatures AT elenaroscucurull insomniasymptomsinpatientswithsubstanceusedisordersduringdetoxificationandassociatedclinicalfeatures AT elenaroscucurull insomniasymptomsinpatientswithsubstanceusedisordersduringdetoxificationandassociatedclinicalfeatures AT elenaroscucurull insomniasymptomsinpatientswithsubstanceusedisordersduringdetoxificationandassociatedclinicalfeatures AT elenaroscucurull insomniasymptomsinpatientswithsubstanceusedisordersduringdetoxificationandassociatedclinicalfeatures AT joseantonioramosquiroga insomniasymptomsinpatientswithsubstanceusedisordersduringdetoxificationandassociatedclinicalfeatures AT joseantonioramosquiroga insomniasymptomsinpatientswithsubstanceusedisordersduringdetoxificationandassociatedclinicalfeatures AT joseantonioramosquiroga insomniasymptomsinpatientswithsubstanceusedisordersduringdetoxificationandassociatedclinicalfeatures AT joseantonioramosquiroga insomniasymptomsinpatientswithsubstanceusedisordersduringdetoxificationandassociatedclinicalfeatures AT carlosroncero insomniasymptomsinpatientswithsubstanceusedisordersduringdetoxificationandassociatedclinicalfeatures AT carlosroncero insomniasymptomsinpatientswithsubstanceusedisordersduringdetoxificationandassociatedclinicalfeatures |